{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:50Z","timestamp":1787242310295,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000007533","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T19:03:49Z","timestamp":1504033429000},"page":"e7533","source":"Crossref","is-referenced-by-count":14,"title":["Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus"],"prefix":"10.1097","volume":"96","author":[{"given":"Honghua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-4-20210226","first-page":"474","article-title":"Glycemic control of adult patients with type 2 diabetes mellitus treated by oral antidiabetic drugs in combination with insulin in China in 2009","volume":"4","author":"Guo","year":"2012","journal-title":"Chin J Diabetes Mellitus"},{"key":"R3-4-20210226","first-page":"397","article-title":"Status of blood glucose control and treatment of type 2 diabetes in China","volume":"4","author":"Ji","year":"2012","journal-title":"Chin J Diabetes Mellitus"},{"key":"R4-4-20210226","first-page":"402","article-title":"Glycaemic control in patients with type 2 diabetes treated with oral antidiabetic drugs in urban areas of China","volume":"4","author":"Lu","year":"2012","journal-title":"Chin J Diabetes Mellitus"},{"key":"R5-4-20210226","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jdiacomp.2014.03.015","article-title":"BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults","volume":"28","author":"Li","year":"2014","journal-title":"J Diabetes Complications"},{"key":"R6-4-20210226","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/gerona\/glt104","article-title":"Worse pancreatic beta-cell function and better insulin sensitivity in older Chinese without diabetes","volume":"69","author":"Xiao","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R7-4-20210226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(13)70021-4","article-title":"Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial","volume":"2","author":"Yang","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R8-4-20210226","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(14)70145-7","article-title":"Causes of type 2 diabetes in China","volume":"2","author":"Ma","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-4-20210226","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/ijcp.12467","article-title":"Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis","volume":"68","author":"Li","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"suppl","key":"R10-4-20210226","first-page":"s81","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"R11-4-20210226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164114525548","article-title":"Force on diabetes, pre-diabetes, cardiovascular diseases of the European Society of Cardiology, European Association for the Study of Diabetes, et al.. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: summary.","volume":"11","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"R12-4-20210226","first-page":"447","article-title":"Diagnosis and treatment of type 2 diabetes mellitus in China","volume":"6","author":"Society","year":"2013","journal-title":"Chin J Diabetes Mellitus"},{"key":"R13-4-20210226","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S2213-8587(13)70107-4","article-title":"Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?","volume":"2","author":"Ma","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R14-4-20210226","first-page":"112","article-title":"An analysis of hypoglycemic agents used among patients with type 2 diabetes in Beijing communities","volume":"53","author":"Chen","year":"2014","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R15-4-20210226","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jdiacomp.2011.06.004","article-title":"The beneficial effect of alpha-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data","volume":"25","author":"Lin","year":"2011","journal-title":"J Diabetes Complications"},{"key":"R16-4-20210226","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1753-0407.12100","article-title":"Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment","volume":"6","author":"Guo","year":"2014","journal-title":"J Diabetes"},{"key":"R17-4-20210226","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1753-0407.12165","article-title":"China type 2 diabetes treatment status survey of treatment pattern of oral drugs users","volume":"7","author":"Ji","year":"2015","journal-title":"J Diabetes"},{"key":"R18-4-20210226","doi-asserted-by":"crossref","first-page":"e0126704","DOI":"10.1371\/journal.pone.0126704","article-title":"Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: a meta-analysis","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:55:06Z","timestamp":1620946506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":18,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007533","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}